TransMedics Group, Inc.
TMDX
$121.31
-$7.66-5.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 105.38M | 24.32M | 34.91M | 25.68M | 6.86M |
| Total Depreciation and Amortization | 6.97M | 6.05M | 6.73M | 6.14M | 5.68M |
| Total Amortization of Deferred Charges | 500.00K | 800.00K | -- | -- | -- |
| Total Other Non-Cash Items | -73.00M | 10.47M | 9.79M | 9.73M | 12.96M |
| Change in Net Operating Assets | -5.34M | 27.93M | 40.19M | -44.40M | -5.83M |
| Cash from Operations | 34.51M | 69.57M | 91.61M | -2.86M | 19.66M |
| Capital Expenditure | -15.51M | -7.62M | -9.08M | -27.04M | -13.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.51M | -7.62M | -9.08M | -27.04M | -13.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.10M | 3.78M | 7.09M | 3.03M | 1.19M |
| Repurchase of Common Stock | 0.00 | -138.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.10M | 3.64M | 7.09M | 3.03M | 1.19M |
| Foreign Exchange rate Adjustments | 94.00K | 9.00K | 809.00K | 358.00K | -687.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.19M | 65.60M | 90.43M | -26.51M | 6.56M |